# KCNIP1

## Overview
KCNIP1 is a gene that encodes the potassium voltage-gated channel interacting protein 1, a member of the Kv channel-interacting proteins (KChIPs) family. This protein is characterized by its EF-hand calcium-binding motifs, which are essential for its role in modulating A-type potassium channels, particularly the Kv4 channels, in the nervous system (Pruunsild2005Structure; Rhodes2004KChIPs). As a neuronal Ca2+ sensor, KCNIP1 functions as a Ca2+-dependent transcriptional regulator, interacting with specific DNA sequences to influence gene transcription (Néant2015Kcnip1; Néant2018Ca2+Dependent). The gene's alternative splicing results in multiple isoforms, which may have distinct functional properties (Pruunsild2005Structure). Clinically, KCNIP1 has been implicated in various conditions, including type 2 diabetes, atrial fibrillation, and attention-deficit/hyperactivity disorder, highlighting its significance in both metabolic and neurological pathways (Lee2014Genomewide; Tsai2016Genomewide; Yuan2017Attentiondeficithyperactivity).

## Structure
The KCNIP1 gene encodes a protein that is part of the Kv channel-interacting proteins (KChIPs) family, characterized by the presence of EF-hand calcium-binding motifs. These motifs are crucial for the protein's function in modulating A-type potassium channels (Pruunsild2005Structure). The protein structure includes a complex exon/intron organization, with multiple alternative transcripts identified. The protein coding region of KCNIP1 mRNA can be either 681 or 675 base pairs, depending on the first exon used (Pruunsild2005Structure).

KCNIP1 undergoes alternative splicing, resulting in different isoforms with distinct N-terminal sequences. A novel 5' exon, exon Ia, encodes 29 amino acids that are not homologous to other KCNIP family proteins, potentially leading to functional isoforms with unique properties (Pruunsild2005Structure). These isoforms can affect the protein's interaction with potassium channels and its role in modulating their surface expression and gating properties (Rhodes2004KChIPs).

Post-translational modifications, such as phosphorylation, may also play a role in the regulation of KCNIP1's function, although specific details on these modifications are not provided in the context. The protein's interaction with Kv4 channels is significant for its role in the nervous system (Rhodes2004KChIPs).

## Function
KCNIP1 encodes a protein that is part of the Kv channel-interacting proteins (KChIPs) family, which modulates the activity of voltage-gated potassium channels, particularly the Kv4 channels. These channels are crucial for neuronal functions, including controlling firing frequency and regulating action potentials. KCNIP1 interacts with Kv4 channels to facilitate their movement to the plasma membrane, a process essential for their function in neurons (Hasdemir2005Traffic). This interaction is dependent on the EF-hand domain of KCNIP1, which is involved in calcium binding, and the myristoylation of KCNIP1 is essential for its function in channel trafficking (Hasdemir2005Traffic).

KCNIP1 is targeted to a novel type of post-ER transport vesicle, distinct from COPII-coated vesicles, suggesting multiple pathways for ER-to-Golgi transport (Hasdemir2005Traffic). In neurons, KCNIP1 is associated with dendritic Golgi outposts, indicating its role in local vesicular traffic (Hasdemir2005Traffic). The regulation of Kv4 channel expression and traffic by KCNIP1 is significant for maintaining normal neuronal excitability and synaptic plasticity (Hasdemir2005Traffic). This protein's activity in the cytoplasm and nucleus impacts processes like synaptic plasticity and heart rhythm regulation.

## Clinical Significance
Mutations and alterations in the expression of the KCNIP1 gene have been implicated in several diseases. In the context of type 2 diabetes (T2D), KCNIP1 is considered a potential susceptibility gene. Studies have shown that inhibiting KCNIP1 can increase insulin secretion in a glucose-dependent manner, suggesting that dysregulation of this gene may affect insulin production and contribute to T2D pathogenesis (Lee2014Genomewide). Additionally, a study in a Chinese population identified a copy number variation (CNV) in KCNIP1 associated with an increased risk of T2D, linking it to higher fasting plasma glucose and glycated hemoglobin levels (Xu2018Divergent).

KCNIP1 is also associated with cardiac conditions, particularly atrial fibrillation (AF). A CNV in the KCNIP1 gene has been identified as a genetic predictor for AF, with the insertion allele linked to increased expression levels and a higher risk of AF. This suggests that KCNIP1 may influence atrial electrophysiology by modulating potassium currents, potentially facilitating AF (Tsai2016Genomewide).

In the realm of neurological disorders, the KCNIP1 gene has been linked to attention-deficit/hyperactivity disorder (ADHD). The rs1541665 SNP in KCNIP1 is associated with an increased risk of ADHD, particularly the inattentive subtype, and may interact with environmental factors such as maternal stress and blood lead levels to modify ADHD risk (Yuan2017Attentiondeficithyperactivity).

## Interactions
KCNIP1, also known as potassium voltage-gated channel interacting protein 1, is a member of the neuronal Ca2+ sensor family and functions as a Ca2+-dependent transcriptional regulator. It interacts with specific DNA sequences known as Downstream Regulatory Element (DRE) sites in a calcium-dependent manner, acting as a transcriptional repressor or activator. This interaction is crucial for controlling gene transcription in various biological processes, including neural development in Xenopus embryos (Néant2015Kcnip1; Néant2018Ca2+Dependent).

KCNIP1 is part of a family of proteins that can form homo or heterotetramers, allowing for functional redundancy among the KCNIP proteins. All four KCNIP proteins, including KCNIP1, can bind to DRE sites, suggesting that they may participate in multiprotein complexes that regulate gene expression (Néant2018Ca2+Dependent).

While specific physical interactions of KCNIP1 with other proteins are not detailed in the provided context, its role as a transcriptional regulator implies potential interactions with other transcription factors and components of the transcriptional machinery. The protein's ability to bind DNA and influence gene expression highlights its importance in cellular signaling pathways and developmental processes (Néant2015Kcnip1).


## References


[1. (Rhodes2004KChIPs) Kenneth J. Rhodes, Karen I. Carroll, M. Amy Sung, Lisa C. Doliveira, Michael M. Monaghan, Sharon L. Burke, Brian W. Strassle, Lynn Buchwalder, Milena Menegola, Jie Cao, W. Frank An, and James S. Trimmer. Kchips and kv4 α subunits as integral components of a-type potassium channels in mammalian brain. The Journal of Neuroscience, 24(36):7903–7915, September 2004. URL: http://dx.doi.org/10.1523/jneurosci.0776-04.2004, doi:10.1523/jneurosci.0776-04.2004. This article has 220 citations.](https://doi.org/10.1523/jneurosci.0776-04.2004)

[2. (Tsai2016Genomewide) Chia-Ti Tsai, Chia-Shan Hsieh, Sheng-Nan Chang, Eric Y. Chuang, Kwo-Chang Ueng, Chin-Feng Tsai, Tsung-Hsien Lin, Cho-Kai Wu, Jen-Kuang Lee, Lian-Yu Lin, Yi-Chih Wang, Chih-Chieh Yu, Ling-Ping Lai, Chuen-Den Tseng, Juey-Jen Hwang, Fu-Tien Chiang, and Jiunn-Lee Lin. Genome-wide screening identifies a kcnip1 copy number variant as a genetic predictor for atrial fibrillation. Nature Communications, February 2016. URL: http://dx.doi.org/10.1038/ncomms10190, doi:10.1038/ncomms10190. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms10190)

[3. (Xu2018Divergent) Yao Xu, Weilin Shi, Ruhui Song, Wenlin Long, Hui Guo, Shiliang Yuan, and Tongcun Zhang. Divergent patterns of genic copy number variation in &lt;i&gt;kcnip1&lt;/i&gt; gene reveal risk locus of type 2 diabetes in chinese population. Endocrine Journal, 65(5):537–545, 2018. URL: http://dx.doi.org/10.1507/endocrj.ej17-0496, doi:10.1507/endocrj.ej17-0496. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1507/endocrj.ej17-0496)

[4. (Lee2014Genomewide) Heun-Sik Lee, Sanghoon Moon, Jun Ho Yun, MeeHee Lee, Mi Yeong Hwang, Young-Jin Kim, Bok-Ghee Han, Jeong-Min Kim, and Bong-Jo Kim. Genome-wide copy number variation study reveals kcnip1 as a modulator of insulin secretion. Genomics, 104(2):113–120, August 2014. URL: http://dx.doi.org/10.1016/j.ygeno.2014.05.004, doi:10.1016/j.ygeno.2014.05.004. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2014.05.004)

[5. (Pruunsild2005Structure) Priit Pruunsild and Tõnis Timmusk. Structure, alternative splicing, and expression of the human and mouse kcnip gene family. Genomics, 86(5):581–593, November 2005. URL: http://dx.doi.org/10.1016/j.ygeno.2005.07.001, doi:10.1016/j.ygeno.2005.07.001. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2005.07.001)

[6. (Néant2015Kcnip1) Isabelle Néant, Britt Mellström, Paz Gonzalez, Jose R. Naranjo, Marc Moreau, and Catherine Leclerc. Kcnip1 a ca2+-dependent transcriptional repressor regulates the size of the neural plate in xenopus. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1853(9):2077–2085, September 2015. URL: http://dx.doi.org/10.1016/j.bbamcr.2014.12.007, doi:10.1016/j.bbamcr.2014.12.007. This article has 13 citations.](https://doi.org/10.1016/j.bbamcr.2014.12.007)

[7. (Yuan2017Attentiondeficithyperactivity) Fang-Fen Yuan, Xue Gu, Xin Huang, Yu-Wei Hou, Yan Zhong, Jun Lin, and Jing Wu. Attention-deficit/hyperactivity disorder associated with kchip1 rs1541665 in kv channels accessory proteins. PLOS ONE, 12(11):e0188678, November 2017. URL: http://dx.doi.org/10.1371/journal.pone.0188678, doi:10.1371/journal.pone.0188678. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0188678)

[8. (Hasdemir2005Traffic) Burcu Hasdemir, Daniel J. Fitzgerald, Ian A. Prior, Alexei V. Tepikin, and Robert D. Burgoyne. Traffic of kv4 k+ channels mediated by kchip1 is via a novel post-er vesicular pathway. The Journal of Cell Biology, 171(3):459–469, October 2005. URL: http://dx.doi.org/10.1083/jcb.200506005, doi:10.1083/jcb.200506005. This article has 80 citations.](https://doi.org/10.1083/jcb.200506005)

[9. (Néant2018Ca2+Dependent) Isabelle Néant, Jacques Haiech, Marie-Claude Kilhoffer, Francisco J. Aulestia, Marc Moreau, and Catherine Leclerc. Ca2+-dependent transcriptional repressors kcnip and regulation of prognosis genes in glioblastoma. Frontiers in Molecular Neuroscience, December 2018. URL: http://dx.doi.org/10.3389/fnmol.2018.00472, doi:10.3389/fnmol.2018.00472. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2018.00472)